- Home
- NOTV vs XOS Comparison
NOTV vs XOS Comparison
Compare NOTV & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- XOS
- Stock Information
- Founded
- NOTV 1974
- XOS 2016
- Country
- NOTV United States
- XOS United States
- Employees
- NOTV N/A
- XOS N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- XOS Construction/Ag Equipment/Trucks
- Sector
- NOTV Health Care
- XOS Consumer Discretionary
- Exchange
- NOTV Nasdaq
- XOS Nasdaq
- Market Cap
- NOTV 62.5M
- XOS 25.6M
- IPO Year
- NOTV 1997
- XOS N/A
- Fundamental
- Price
- NOTV $1.94
- XOS $3.40
- Analyst Decision
- NOTV Strong Buy
- XOS Buy
- Analyst Count
- NOTV 1
- XOS 5
- Target Price
- NOTV $5.00
- XOS $8.80
- AVG Volume (30 Days)
- NOTV 514.6K
- XOS 17.3K
- Earning Date
- NOTV 08-07-2025
- XOS 08-12-2025
- Dividend Yield
- NOTV N/A
- XOS N/A
- EPS Growth
- NOTV N/A
- XOS N/A
- EPS
- NOTV N/A
- XOS N/A
- Revenue
- NOTV $480,402,000.00
- XOS $48,678,000.00
- Revenue This Year
- NOTV $4.99
- XOS $1.45
- Revenue Next Year
- NOTV $5.39
- XOS $27.16
- P/E Ratio
- NOTV N/A
- XOS N/A
- Revenue Growth
- NOTV N/A
- XOS N/A
- 52 Week Low
- NOTV $1.15
- XOS $2.73
- 52 Week High
- NOTV $6.48
- XOS $9.15
- Technical
- Relative Strength Index (RSI)
- NOTV 44.40
- XOS 63.01
- Support Level
- NOTV $1.97
- XOS $3.17
- Resistance Level
- NOTV $2.30
- XOS $3.50
- Average True Range (ATR)
- NOTV 0.15
- XOS 0.14
- MACD
- NOTV 0.02
- XOS 0.06
- Stochastic Oscillator
- NOTV 49.22
- XOS 86.00
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.